IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts

Biologics: Targets and Therapy

Volumn 2, Issue 3, 2008, Pages 583-591

  Tamby, Mathieu C ^a   Servettaz, Amélie ^a   Tamas, Nicolas ^a   Reinbolt, Joseph ^b   Caux, Frédéric ^c   Meyer, Olivier ^d   Allanore, Yannick ^e   Kahan, André ^e   Guillevin, Loïc ^a   Mouthon, Luc ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d BICHAT HOSPITAL   (France)

^e université Paris Cité   (France)

Author keywords

Autoantibodies; DNA topoisomerase 1; Fibroblast; IgG; Systemic sclerosis

Indexed keywords

EID: 79955433879     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alderuccio F, Witherden D, Toh BH, et al. 1989. Autoantibody to gp50, a glycoprotein shared in common between fibroblasts and lymphocytes, in progressive systemic sclerosis. Clin Exp Immunol, 78:26-30.
2. Artlett CM, Smith JB, Jimenez SA. 1998. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med, 338:1186-91.
3. Baroni SS, Santillo M, Bevilacqua F, et al. 2006. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med, 354:2667-76.
4. Brentnall TJ, Kenneally D, Barnett AJ, et al. 1982. Autoantibodies to fibroblasts in scleroderma. J Clin Lab Immunol, 8:9-12.
5. Briolay J, Gioud M, Monier JC, et al. 1989. Antinuclear antibodies detected by indirect immunofluorescence on HEp2 cells and by immunoblotting in patients with systemic sclerosis. Autoimmunity, 2:165-76.
6. Bunn CC, Denton CP, Shi-Wen X, et al. 1998. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol, 37:15-20.
7. Chanseaud Y, Pena-Lefebvre PG, Guilpain P, et al. 2003. IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin Immunol, 109:165-78.
8. Chizzolini C, Raschi E, Rezzonico R, et al. 2002. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum, 46:1602-13.
9. Garcia de la Pena-Lefebvre P, Chanseaud Y, Tamby MC, et al. 2004. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients. Clin Immunol, 111:241-51.
10. Henault J, Tremblay M, Clement I, et al. 2004. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum, 50:3265-74.
11. Ihn H, Sato S, Fujimoto M, et al. 2000. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol, 119:203-9.
12. Kumar V, Kowalewski C, Koelle M, et al. 1988. Scl-70 antigen stability and its effect on antibody detection in scleroderma. J Rheumatol, 15:1499-502.
13. Leask A, Holmes A, Abraham DJ. 2002. Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep, 4:136-42.
14. LeRoy EC, Black C, Fleischmajer R, et al. 1988. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol, 15:202-5.
15. Messer M, Griffiths M, Rismiller PD, et al. 1997. Lactose synthesis in a Monotreme, the Echidna (Tachyglossus aculeatus): isolation and amino acid sequence in Echidna a-lactalbumin. Comp Biochem Physiol, 118b:403-10.
16. Moroi Y, Peebles C, Fritzler MJ, et al. 1980. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA, 77:1627-31.
17. Mouthon L, Lacroix-Desmazes S, Barreau C, et al. 1996. The repertoire of antibody reactivities of normal human serum IgM with self antigens is acquired in early childhood and remains stable throughout life. Scand J Immunol, 44:243-51.
18. Mouthon L, Nobrega A, Nicolas N, et al. 1995. Invariance and restriction towards a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sci USA, 92:3839-43.
19. Mukerjee D, St George D, Coleiro B, et al. 2003. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis, 62:1088-93.
20. Nelson JL, Furst DE, Maloney S, et al. 1998. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet, 351:559-62.
21. Nobrega A, Haury M, Grandien A, et al. 1993. Global analysis of antibody repertoires. II. Evidence for specificity, self-selection and the immunological 'homunculus' of antibodies in normal serum. Eur J Immunol, 23:2851-259.
22. Ronda N, Gatti R, Giacosa R, et al. 2002. Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolinlinked pathway. Arthritis Rheum, 46:1595-601.
23. Servettaz A, Agard C, Tamby M, et al. 2006. Physiopathologie de la sclérodermie systémique: état des lieux sur une affection aux multiples facettes. Presse Med, 35:1903-15.
24. Sgonc R, Gruschwitz M, Boeck G, et al. 2000. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum, 43:2550-62.
25. Steen VD, Powell DL, Medsger TAJ. 1988. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum, 31:196-203.
26. Tamby MC, Chanseaud Y, Guillevin L, et al. 2003. New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev, 2:152-7.
27. Tamby MC, Chanseaud Y, Humbert M, et al. 2005. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax, 60:765-72.
28. Tan FK, Arnett FC, Antohi S, et al. 1999. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol, 163:1066-72.
29. Weiner ES, Earnshaw WC, Senecal JL, et al. 1988. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. Arthritis Rheum, 31:378-85.
30. Zhou X, Tan FK, Milewicz DM, et al. 2005. Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the "scleroderma phenotype". J Immunol, 175:4555-60.